Please login to the form below

Cornerstone Therapeutics

This page shows the latest Cornerstone Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Chiesi hits the acquisition trail again

Chiesi hits the acquisition trail again. Will buy US speciality pharma company Cornerstone. ... Italy's Chiesi has signed its second acquisition deal in as many months, agreeing a $9.50-a-share deal for US speciality pharma company Cornerstone

Latest news

Cornerstone slumps as FDA panel votes down lead pipeline drug

US pharma company Cornerstone Therapeutics suffered a setback after an FDA advisory committee voted against approval of lixivaptan, the firm's drug candidate for hyponatremia or low sodium levels in the ... It was originally developed by Wyeth and
Pharma deals for May 2012

This can effectively kill a deal and potentially the product. Another example of a product acquisition is InterMune's sale of its approved product, Actimmune (interferon gamma-1b), to Vidara Therapeutics ... NCEs for respiratory disease. 212. EKR
Biologics buoyant

Three of the deals, with Amplimmune, FivePrime Therapeutics and Genmab, focus on biologics. ... 84+. Cornerstone Therapeutics/Targacept . Alpha-7 and other nicotinic receptor targeting compounds. Preclinical .

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Deal Watch table for September 2013

Cornerstone Therapeutics/ Chiesi Farmaceutici. Acquisition (42 per cent). US speciality pharmaceutical company focused hospital and niche respiratory products. ... Cornerstone Therapeutics, respectively.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Medical Writer, MedComms Agency: Salary TBC

Digital Account Director – Health/ Pharma – Global Agency: Salary TBC

Science Writer, Healthcare Advertising Agency: £40, 000 - 45, 000 DOE benefits,

Account Director, Healthcare Communications Agency: £54, 000- £60, 000

Market Access Consultant - Greater Manchester: Negotiable

Deputy Managing Director – Healthcare PR – Global Agency: Negotiable

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Account Manager, MedicalCommunications/ Healthcare PR: benefits

Integrated Brand/ Digital Senior Account Director, London: Excellent package

Account Manager- 4 days per week or full-time: Salary TBC

Associate Scientific Director: Salary TBC

Senior Account Manager – Healthcare Advertising: Salary TBC

Graduate Scientific Editor: DOE

Senior Medical Writer: Salary is DOE

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Senior Strategist/ Planner, Healthcare Marketing, London: Excellent package

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Healthcare PR Senior Account Manager: Salary TBC

Medical Writers Required - Hertfordshire: Competitive

Senior Medical Writer, Principal Medical Writer, Scientific Dire...: £40000 - £75000 Bonus Benefits

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Sudler London - Senior Medical Writer: Competitive

Senior Writer, Healthcare Advertising, London: Excellent package

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Subscribe to our email news alerts

PMHub

Add my company

bmore group

OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....

Latest intelligence

PM Society Digital Awards – the power of together: Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduce anyone in four simple steps: You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government: GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....